Pharmafile Logo
Pharmafocus logo
Advanced Search

Heart progress trumpeted by Labour

March 9, 2005

The government has trumpeted its progress on tackling the UK's biggest killer, cardiovascular disease, and launched a new chapter of …

News

Potential blockbuster Tysabri pulled after patient death

March 9, 2005
Sales and Marketing

Elan and Biogen Idec have stopped marketing Tysabri (natalizumab), their new multiple sclerosis treatment, and asked doctors not to prescribe …

News

ABPI to oppose strictest measures in pan-European code of practice

March 3, 2005
Sales and Marketing

A pan-European code of practice is being drawn up by the pharmaceutical industry organisation EFPIA in response to continuing criticism …

News

GSK rebrands AIDS drugs to foil illegal imports

March 2, 2005
Sales and Marketing

GlaxoSmithKline has rebranded its Aids drugs supplied to sub-Saharan Africa to stop illegal re-importation to Europe.The company said parallel importers …

News

Quicker service for cancer patients but ‘black spots’ persist

March 2, 2005

Cancer patients are being seen more quickly but there is still room for improvement, says a National Audit Office report …

News

NICE acts to speed lung cancer diagnosis and treatment

March 2, 2005

Patients showing symptoms of lung cancer should be offered an urgent referral to a chest physician, according to NICE recommendations …

News

Singulair gains dual asthma-hayfever indication

March 2, 2005
Sales and Marketing

Merck Sharpe & Dohme's blockbuster oral asthma treatment Singulair has received an expanded UK licence for the treatment of adult …

News

NICE U-turn will ‘set Alzheimer’s treatment back 10 years’

March 2, 2005

News

NHS is behind us, says rep-free Takeda

March 1, 2005
Sales and Marketing Davis, Takeda, sales and marketing

Takeda UK says new market research shows healthcare professionals and NHS managers are in favour of its revolutionary move away …

News

Cymbalta approved for second indication

February 24, 2005
Sales and Marketing

Cymbalta has received European approval for diabetic peripheral neuropathic pain (DPNP) in adults, with its marketers keen to meet what …

News

Reassessing medical communications

February 24, 2005

It's time to be less defensive about perfectly legitimate medical communications methods providing contentious 'sharp practices' can be consigned to …

Feature

Private sector involvement in NHS continues to grow

February 24, 2005

News

Sankyo and Daiichi set to continue Japanese consolidation

February 24, 2005
Sales and Marketing

Two of Japan's leading pharmaceutical companies Sankyo and Daiichi look set to merge later this year, accelerating consolidation in the …

News

Novartis becomes generic world leader

February 24, 2005
Sales and Marketing

News

MHRA to get tough on ‘unethical’ pharma advertising

February 23, 2005

News

FDA panel clears Vioxx return to market

February 21, 2005
Sales and Marketing

An FDA panel has narrowly voted in favour of allowing Vioxx to return to the market, after concluding it carries …

News

IMS and Innovex announce UK alliance

February 17, 2005
Sales and Marketing

Pharma data consultants IMS have announced a new alliance with contract sales provider Innovex to supply its field forces with …

News

Garnier hints at large-scale cutbacks to global salesforce

February 17, 2005
Sales and Marketing

News

ADHD latest drugs to be hit by safety warnings

February 17, 2005
Sales and Marketing

Attention deficit hyperactivity disorder (ADHD) treatments are the latest class of drugs to be hit by safety warnings, with regulators …

News

New FDA drug safety board to be more independent

February 17, 2005
Sales and Marketing

A new independent FDA board will be set up to monitor drug safety and issue warnings to doctors and patients …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025